MEDESIS PHARMA (EPA:ALMDP)

REGULATED PRESS RELEASE

published on 11/20/2024 at 17:45, 1 month ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 2 months 13 days ago

MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)
BRIEF

published on 09/20/2024 at 08:05, 3 months 1 day ago

Encouraging results from NanoLithium trial on Alzheimer's disease

Biotechnology Alzheimer Nanolithium Clinical Trial Tolérance
REGULATED PRESS RELEASE

published on 07/15/2024 at 08:00, 5 months 6 days ago

MEDESIS PHARMA: 2023 FULL-YEAR BUSINESS AND EARNINGS
REGULATED PRESS RELEASE

published on 03/19/2024 at 18:01, 9 months 1 day ago

Termination of the agreement between NICE and GREEN S.A. and Medesis Pharma
REGULATED PRESS RELEASE

published on 01/29/2024 at 18:00, 10 months 22 days ago

MEDESIS PHARMA : Phase 2 clinical trial for the treatment of Alzheimer's disease - Completion of the 1st phase of double-blind treatment, with good patient retention and acceptance of the treatment
MEDESIS PHARMA successfully completes Phase 2 clinical trial for Alzheimer's disease, announces Nanolithium scientific publication, participation in BIOMED Forum, and a new cash contribution

Medesis Pharma Phase 2 Clinical Trial Alzheimer's Disease Nanolithium BIOMED Forum
REGULATED PRESS RELEASE

published on 10/27/2023 at 18:00, 1 year 1 month ago

MEDESIS PHARMA: 2023 FIRST-HALF BUSINESS AND EARNINGS
REGULATED PRESS RELEASE

published on 10/23/2023 at 18:00, 1 year 1 month ago

MEDESIS PHARMA PARTICIPATES IN THE 16th INTERNATIONAL CONGRESS “CLINICAL TRIALS ON ALZHEIMER DISEASE” (CTAD) IN BOSTON FROM OCTOBER 24 TO 27, 2023 AND PRESENTS A POSTER ON ITS CURRENT RESEARCH
REGULATED PRESS RELEASE

published on 10/17/2023 at 08:00, 1 year 2 months ago

END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE
REGULATED PRESS RELEASE

published on 10/11/2023 at 18:00, 1 year 2 months ago

MEDESIS PHARMA: PUBLICATION OF A SCIENTIFIC ARTICLE IN THE JOURNAL OF ALZHEIMER’S DISEASE ON THE USE OF LITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Published on 12/21/2024 at 01:30, 13 hours 14 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 13 hours 14 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 14 hours 39 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 14 hours 44 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 15 hours 14 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 13 hours 53 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 59 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 19 hours 34 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 19 hours 48 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 20 hours 44 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 2 hours 27 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 20 hours 44 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 20 hours 49 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 20 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News